Anuj Suri, MD

Assistant Professor of Clinical Obstetrics and Gynecology, Academic Institute
Houston Methodist


Biography

Dr. Suri is a gynecologic oncologist in the Department of Obstetrics and Gynecology at Houston Methodist Hospital. He grew up in Knoxville, Tennessee and received his medical degree from The University of Tennessee in Memphis in 2006. He completed a four year residency in the Department of Obstetrics, Gynecology, and Reproductive Sciences from the University of Texas Medical School in Houston Memorial Hermann Hospital. While a resident, he completed a one month Felix Rutledge Fellowship at The University of Texas MD Anderson Cancer Center and won the J. Taylor Wharton Award for Outstanding Resident in Gynecologic Oncology.

After completion of residency in 2010, Dr. Suri completed his Gynecologic Oncology Fellowship at the University of North Carolina Hospitals in Chapel Hill, North Carolina. During his training, Dr. Suri won several awards including Best Oral Presentation at the Winter Meeting of the Society of Gynecologic Oncology in 2012, the ASCO Merit Award at the 2012 American Society of Clinical Oncology Annual meeting, and The Golden Tarheel Award at The University of North Carolina. Dr. Suri has conducted basic science and clinical research covering topics such as ovarian cancer, granulosa cell tumors of the ovary, and vulvar cancer and presented his research at national conferences.

Description of Research

Dr. Suri has extensive surgical and clinical training in the field of minimally invasive and robotic surgery. He also specializes in fertility sparing treatments and surgery for certain gynecologic cancers. He uses his clinical experience and multidisplinary approach to treat women with gynecologic cancers. 

Professional Activity

  • Texas Association of Obstetrics and Gynecology
  • The Society of Gynecologic Oncologists
  • American Society of Clinical Oncology
  • Houston Methodist Cancer Center

Publications

The association between progesterone receptor expression and survival in women with adult granulosa cell tumors
Puechl, AM, Edwards, J, Suri, A, Nakayama, J, Bean, S, Gehrig, P, Saks, E, Duska, L, Broadwater, G, Ehrisman, J, Horowitz, N & Secord, AA 2019, , Gynecologic oncology, vol. 153, no. 1, pp. 74-79. https://doi.org/10.1016/j.ygyno.2019.01.016

The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer
Suri, A, Sheng, X, Schuler, KM, Zhong, Y, Han, X, Jones, HM, Gehrig, PA, Zhou, C & Bae-Jump, VL 2016, , Oncotarget, vol. 7, no. 26, pp. 39582-39594. https://doi.org/10.18632/oncotarget.8659

Factors associated with an increased risk of recurrence in women with ovarian granulosa cell tumors
Suri, A, Carter, EB, Horowitz, N, Denslow, S & Gehrig, PA 2013, , Gynecologic oncology, vol. 131, no. 2, pp. 321-324. https://doi.org/10.1016/j.ygyno.2013.08.013

Pre-operative imaging with CA125 is a poor predictor for granulosa cell tumors
Stine, JE, Suri, A, Gehrig, PA, Chiu, M, Erickson, BK, Huh, WK, Soper, JT, Le, LV, Conner, MG & Kim, KH 2013, , Gynecologic oncology, vol. 131, no. 1, pp. 59-62. https://doi.org/10.1016/j.ygyno.2013.06.030

Minimally invasive surgery in endometrial cancer: Recent updates
Doll, KM, Suri, A & Gehrig, PA 2013, , Expert Review of Obstetrics and Gynecology, vol. 8, no. 3, pp. 271-283. https://doi.org/10.1586/eog.13.14

Discussion: 'Ovarian epithelial carcinoma with pelvic endometriosis,' by Wang et al
Van Le, L, Jackson, A, Schuler, K, Suri, A, Doll, K, Stine, J & Kim, K 2013, , American Journal of Obstetrics and Gynecology, vol. 208, no. 5, pp. e1-e2. https://doi.org/10.1016/j.ajog.2013.03.014

Ovarian epithelial carcinoma with pelvic endometriosis: Wang et al
Van Le, L, Jackson, A, Schuler, K, Suri, A, Doll, K, Stine, J & Kim, K 2013, , American Journal of Obstetrics and Gynecology, vol. 208, no. 5, pp. 415-416. https://doi.org/10.1016/j.ajog.2013.03.004

Surgical staging in early ovarian carcinoma: Garcia-Soto et al
Van Le, L, Jackson, A, Schuler, K, Suri, A, Kilgore, J, Ko, E, Gehrig, P & Brewster, W 2012, , American Journal of Obstetrics and Gynecology, vol. 206, no. 3, pp. 263-264. https://doi.org/10.1016/j.ajog.2012.01.019

Discussion: 'Surgical staging in early ovarian carcinoma' by Garcia-Soto et al
Van Le, L, Jackson, A, Schuler, K, Suri, A, Kilgore, J, Ko, E, Gehrig, P & Brewster, W 2012, , American Journal of Obstetrics and Gynecology, vol. 206, no. 3, pp. e1-e3. https://doi.org/10.1016/j.ajog.2012.01.020

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations missed opportunities
Meyer, LA, Anderson, ME, Lacour, RA, Suri, A, Daniels, MS, Urbauer, DL, Nogueras-Gonzalez, GM, Schmeler, KM, Gershenson, DM & Lu, KH 2010, , Obstetrical and Gynecological Survey, vol. 65, no. 7, pp. 436-437. https://doi.org/10.1097/OGX.0b013e3181e62f2d

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: Missed opportunities
Meyer, LA, Anderson, ME, Lacour, RA, Suri, A, Daniels, MS, Urbauer, DL, Nogueras-Gonzalez, GM, Schmeler, KM, Gershenson, DM & Lu, KH 2010, , Obstetrics and Gynecology, vol. 115, no. 5, pp. 945-952. https://doi.org/10.1097/AOG.0b013e3181da08d7

Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer
Suri, A, Frumovitz, M, Milam, MR, dos Reis, R & Ramirez, PT 2009, , Gynecologic oncology, vol. 112, no. 1, pp. 110-113. https://doi.org/10.1016/j.ygyno.2008.09.011